<DOC>
	<DOCNO>NCT01042119</DOCNO>
	<brief_summary>The neurotoxin Botox ( botulinum neurotoxin type A ) show effective treatment therapy refractory overactive bladder syndrome . Our data suggest long efficacy know use striated muscle . The aim study analyze short- longterm efficacy Botox treatment evaluate risk factor non-responders side effect urinary retention .</brief_summary>
	<brief_title>Intravesical Injection Botox Treating Therapy Refractory Overactive Bladder Females</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>intravesical treatment Botox clinic</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>botulinum neurotoxin type A</keyword>
	<keyword>BoNT/A</keyword>
	<keyword>Botox</keyword>
	<keyword>overactive bladder syndrome</keyword>
</DOC>